Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms


In Taiwan, some hospitals reward physicians through financial incentive plans linked to the amount of revenue generated by the drugs they prescribe to patients. This study investigates whether the prescription behavior of physicians impacts the implementation of the government’s drug price adjustment policy, which reduces the amount of reimbursement for certain drugs. Our objective is to determine if the policy is effective. To this end, we consider the drugs prescribed to a specific category of patients, namely, hospital outpatients aged 65 and above with hypertension. Between December 1999 and July 2000, approximately 468,000 prescriptions were issued to such patients. First, we used regression analysis to examine the effect of financial incentives offered to physicians on drug utilization after the implementation of the drug price adjustment policy. Then, we employed a probit model to investigate changes in physicians’ prescription behavior for drugs with and without reduced prices.

The results show that hospitals with physician incentive programs have more drug treatment days and a higher number of drugs per prescription after implementation of a price adjustment policy. In addition, we found that drugs without reduced prices were prescribed more often than reduced-price drugs, which suggests that the financial incentives offered to physicians may have an impact on the implementation of drug cost containment mechanisms. Taiwan’s experience provides a good opportunity to examine, simultaneously, the effects of cost containment mechanisms and physicians’ incentives within a staff-model context.

This is a preview of subscription content, access via your institution.


  1. 1.

    Morgan SG. Booming prescription drug expenditure: a population-based analysis of age dynamics. Med Care. 2005;43:996–1008.

    Article  Google Scholar 

  2. 2.

    Sylvain M. Drugs costing Canada $25 billion annually: CIHI. Med Post. 2006;42(19):5.

    Google Scholar 

  3. 3.

    Dickson M. Global drug plan trends. Benefits Canada. 2006;30(2):F2.

    Google Scholar 

  4. 4.

    Liu SZ, Romeis JC. Assessing the effect of Taiwan’s outpatient prescription drug co-payment policy in the elderly. Med Care. 2003;41:1331–1342.

    Article  Google Scholar 

  5. 5.

    Cheng TM. Taiwan’s new National Health Insurance program: genesis and experience so far. Health Aff. 2003;22(3):61–76.

    Article  Google Scholar 

  6. 6.

    Chu HL, Liu SZ, Yaung CL, Romeis JC. Does the implementation of responsibility centers, total quality management, and physician fee programs improve hospital efficiency—evidence from Taiwan hospitals. Med Care. 2002;40:1233–1237.

    Article  Google Scholar 

  7. 7.

    Chu HL, Liu SZ, Romeis JC. The initial effects of physician compensation programs in Taiwan hospitals: implications for staff model HMOs. Health Care Manag Sci. 2003:6(1): 17–26.

    Article  Google Scholar 

  8. 8.

    Schneeweiss S, Walker AM, Glynn RJ, et al. Outcomes of reference pricing for angiotensin-converting inhibitors. N Engl J Med. 2002;346: 822–829.

    Article  Google Scholar 

  9. 9.

    Kanavos P, Reinhardt U. Reference pricing for drugs: is il compatible with U.S. health care. Health Aff. 2003;22(3): 16–30.

    Article  Google Scholar 

  10. 10.

    Menon D. Pharmaceutical cost control in Canada: does it work? Health Aff. 2001;20(3):92–103.

    CAS  Article  Google Scholar 

  11. 11.

    Hillman AL, Pauly MV, Escarce JJ, et al. Financial incentives and drug spending in managed care. Health Aff. 1999;18(2):189–200.

    CAS  Article  Google Scholar 

  12. 12.

    Greene WH. Econometric Analysis, 6th ed. New Jersey: Prentice Hall; 2008.

    Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Hsuan-Lien Chu PhD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chu, HL., Liu, SZ. & Romeis, J.C. Do Drug Price Adjustment Policies Work? The Impact of Physician Financial Incentive Plans on the Implementation of Drug Cost Containment Mechanisms. Ther Innov Regul Sci 44, 189–198 (2010).

Download citation

Key Words

  • Physician incentive program
  • Drug price adjustment policy
  • Hypertension